ApcinteX Archives – Cambridge Enterprise

Pipettes

Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant

16 February 2022

2021 Annual Review reports success for Cambridge Enterprise

27 January 2022

Three Cambridge spin-outs join Centessa Pharmaceuticals, launched today with a $250m Series A round

16 February 2021

Cambridge spin-out ApcinteX shares clinical trial results from its study of SerpinPC

05 February 2021

Cambridge spin-out ApcinteX begins dosing haemophilia patients in second part of clinical trial

Cambridge spin-out ApcinteX starts clinical trials of novel haemophilia drug

22 October 2019

Annual awards recognise Cambridge innovation and excellence

Spin-out Z Factor announces £7 million Series A funding to bring lung treatment to the clinic

XO1

Potential new treatment for haemophilia developed by Cambridge researchers

27 October 2016